LCN2 and acute kidney injury: Our data indicates that urinary NGAL and serum cystatin C individually can predict AKI and represent a novel biomarker for AKI and may enable clinicians to initiate timely intervention in management of AKI and may prevent long term poor prognostic situations in this particular group of patients.